Exosomes are the hottest word in skincare right now. Every brand is rushing to market an exosome serum with claims about nanosized vesicles delivering regenerative cargo directly to your cells. The science behind exosomes is real — a 2026 PRISMA-compliant systematic review of 19 human studies confirmed exosome-based therapies improved hydration, elasticity, wrinkles, pores, pigmentation, AND overall appearance (PMC12933354). But the exosome serum you are buying may be giving you exosomes WITHOUT the biological conversation those exosomes were designed to deliver.
Here is why that matters. An RCT confirmed elasticity increased +11.3% in the exosome group versus -3.3% in controls — meaning the control group LOST elasticity while the exosome group gained it (p=0.002) (MDPI 2025, Biomedicines). But those results came from MSC-derived exosomes delivered as part of the complete secretome — not isolated exosomes stripped from their growth factor context. Bradceuticals Gold Mesenchymal Stem Cell Growth Factor Serum delivers exosomes the way your cells produce them — embedded inside the complete bone marrow MSC secretome alongside EGF, FGF, TGF-beta, VEGF, PDGF, and HGF. Here is why that distinction changes everything.
Truth 1: Your Exosome Serum May Contain Exosomes Without Context
Exosomes are nanosized extracellular vesicles (30-150nm) that carry proteins, lipids, and microRNA between cells. They are powerful biological messengers. But in nature, exosomes are never released alone — they are secreted as part of a complete secretome that includes growth factors, cytokines, and extracellular matrix proteins working together as a biological conversation.
Many exosome serum products isolate exosomes from this context. Isolated exosomes deliver microRNA without the growth factor signaling that tells cells what to DO with that microRNA. Research confirms up to 80% of MSCs’ therapeutic effect comes from their complete secreted output (PMC11518787). An exosome serum with isolated vesicles delivers a fraction of the conversation. Bradceuticals delivers the whole conversation.
Truth 2: The Best Exosome Serum Contains Growth Factors Too
The clinical trials that produced the dramatic results driving the exosome trend used MSC-derived exosomes delivered within conditioned media — not purified exosomes alone. Scar thickness reduced 32.5% vs 19.9% control. Skin texture improved 12.4-14.4% vs 6.6-7.1% control. Elasticity increased +11.3% vs -3.3% control (MDPI 2025).
Those results came from exosomes PLUS growth factors PLUS cytokines working together. EGF commands collagen synthesis through EGFR receptor binding. FGF stimulates fibroblast proliferation. TGF-beta regulates extracellular matrix production. The exosomes deliver microRNA that fine-tunes these processes at the genetic level (PMC10333026). An exosome serum that strips away the growth factors strips away the instruction.
Truth 3: Your Exosome Serum Should Build AND Protect
The complete secretome does something isolated exosomes cannot: simultaneously build new collagen AND prevent existing collagen from being destroyed. EGF inhibits inflammatory cytokines IL-1alpha, IL-8, and TNF-alpha (PMC10333026). MSC exosomes restore TIMP-1 and inhibit MMP-1 through -9 (PMC12395928). A 2021 study confirmed bone marrow MSC conditioned media produces significantly higher collagen AND elastin production (PMC7904527).
Building new collagen while MMP enzymes destroy existing collagen produces zero net gain. The exosome serum that delivers the complete secretome provides construction AND demolition prevention from every application.
Truth 4: Results From the Right Exosome Serum Are Structural
Visible improvement confirmed from conditioned media applied twice daily for just 4 weeks (PMC6002314). Biopsy-confirmed collagen, elastin, and decorin increases at 24 weeks. Participants perceived themselves six years younger (PMC9823186). New collagen persists five to seven years (PMC11993440).
Not temporary plumping. Structural change verified under a microscope. The exosome serum that delivers the complete secretome produces results that last years — not the weeks most isolated exosome products promise.
Truth 5: Microneedling Unlocks Your Exosome Serum’s Full Potential
Split-face trials confirmed exosome treatments combined with microneedling improved hydration, elasticity, and pigmentation more than microneedling alone (PMC12933354). A randomized controlled trial confirmed one session with growth factors matched four without (PMC7716740). Your exosome serum works on intact skin daily. Through microneedling channels, the complete secretome reaches fibroblasts directly.
Good daily. Transformative through channels. The upgrade path is built into the biology.
The Complete Exosome Serum Routine
Morning: Cleanse → Bradceuticals Growth Factor Serum on damp skin → Cosmedica HA Serum → moisturizer → mineral sunscreen SPF 30+
Evening: Cleanse → Bradceuticals Growth Factor Serum on damp skin → The Ordinary Niacinamide 10% + Zinc 1% → CeraVe Moisturizing Cream
Monthly (optional amplification): Microneedling → Bradceuticals immediately after on damp skin
Essential: Patch test before first use. Apply behind the ear. Wait 24-48 hours.
Frequently Asked Questions
Is an exosome serum better than a growth factor serum? This is the wrong question. The best exosome serum IS a growth factor serum. MSC conditioned media contains both — exosomes delivering microRNA AND growth factors delivering receptor-specific instruction. Choosing between them means choosing an incomplete product.
How is Bradceuticals an exosome serum? Bradceuticals delivers bone marrow MSC conditioned media — the complete secretome naturally containing exosomes, growth factors, cytokines, and extracellular matrix proteins. No isolation. No stripping. The full biological conversation.
How long before an exosome serum shows results? Visible improvement at 4 weeks. Structural collagen confirmed by biopsy at 24 weeks. New collagen persists five to seven years.
Is an exosome serum safe for sensitive skin? EGF inhibits inflammatory cytokines — making the complete secretome among the gentlest actives available. No burning, no peeling, no sun sensitivity.
References
- Flores Rodríguez JC, et al. Efficacy of Exosome-Based Therapies for Skin Rejuvenation. Cureus. 2026;18(2):e104182. (PMC12933354)
- Alzahrani A, et al. Exosomes in Skin Rejuvenation: Systematic Review. Dermatol Pract Concept. 2026;16(1):6462. (DPC 2026)
- MSC-Exosome Therapies for Scars, Aging, Hyperpigmentation. Biomedicines. 2025;8(4):268. (MDPI 2025)
- Taub A. Regenerative topical skincare: stem cells and exosomes. Front Med. 2024;11:1443963. (PMC11518787)
- Shin SH, et al. The use of epidermal growth factor in dermatological practice. Int Wound J. 2023;20(6):2414-2423. (PMC10333026)
- Gui Q, et al. Extracellular vesicles derived from MSCs to treat skin aging. Precis Clin Med. 2024;7(1):pbae004. (PMC12395928)
- Kim SN, et al. Effects of Human BM-MSC-CM on Skin Rejuvenation. Int J Stem Cells. 2021;14(1):94-102. (PMC7904527)
- Kim YJ, et al. Anti-aging Properties of EPC-CM. Dermatol Ther (Heidelb). 2018;8(2):261-273. (PMC6002314)
- Naughton GK, et al. Targeting Multiple Hallmarks of Skin Aging. Dermatol Ther. 2023;13(1):169-186. (PMC9823186)
- Tehrani L, et al. Physiological Mechanisms and Therapeutic Applications of Microneedling. Cureus. 2025;17(3):e80510. (PMC11993440)
- Merati M, et al. An Assessment of Microneedling with Topical Growth Factors. J Clin Aesthet Dermatol. 2020;13(11):22-27. (PMC7716740)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. The products discussed are cosmetic products and are not intended to diagnose, treat, cure, or prevent any disease. Individuals with any active skin condition, pre-existing medical condition, or those currently under the care of a physician or specialist should consult their healthcare provider before beginning any new skincare regimen. Always perform a patch test before using any new skincare product. Consult a qualified healthcare provider before beginning any microneedling protocol. Individual results may vary.
Last Reviewed: April 2026